PFA	Pulsed field ablation
PVI	Pulmonary vein isolation
PV	Pulmonary vein
AF/AFIB	Atrial fibrillation
LAMR	Left atrial macro- as well as micro-reentrant atrial tachycardia
RSPV	Right superior pulmonary vein
AT	Atrial tachycardia
RCT	Randomized controlled trial
RF	Radiofrequency
LDH	Lactate dehydrogenase
HB	Hemoglobin
GDMT	Guideline-directed medical therapy
CIEDs	Cardiac implantable electronic devices
CHD	Coronary heart disease
HFrEF	Heart failure with reduced ejection fraction
HFpEF	Heart failure with preserved ejection fraction
TIA	Transient ischemic attack
HCM	Hypertrophic cardiomyopathy
ICM	Ischemic cardiomyopathy
NYHA	New York Heart Association [staging of heart failure I–IV]
CTI	Cavotricuspid isthmus
DOACs	Direct oral anticoagulants
AARs	Antiarrhythmics
ACE/ARB	Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker
SGLT2	Sodium glucose transporter 2
GLP-1	Glucagon-like peptide-1
NT-pro BNP	N-terminal pro b-type natriuretic peptide
CRP	C-reactive protein
INR	International Normalized Ratio
aPTT	Activated partial thromboplastin time
BUN	Blood urea nitrogen
GOT	Glutamate oxaloacetate transaminase
GPT	Glutamate pyruvate transaminase
LVEF	Left ventricular ejection fraction
LA	Left atrium
RA	Right atrium
IVS	Interventricular septum
LV	Left ventricle
RV	Right ventricle
MI	Mitral insufficiency
TI	Tricuspid insufficiency